Financhill
Buy
54

CORBF Quote, Financials, Valuation and Earnings

Last price:
$1.05
Seasonality move :
-3.66%
Day range:
$0.95 - $0.95
52-week range:
$0.25 - $2.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.60x
P/B ratio:
0.17x
Volume:
--
Avg. volume:
247.9K
1-year change:
-29.63%
Market cap:
$127.2M
Revenue:
--
EPS (TTM):
--

Earnings Data

Next earnings date for CORBF
May 15
2025
Most recent earnings per share
$0.14
Beat by $0.14
(Mar 31/2022)
Consensus Estimate
--
(Mar 31/2022)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CORBF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2022 Q1 -- $46.8M $0.14 -- --
12/31/2021 Q4 -- $49.6M $0.17 -- --
09/30/2021 Q3 -- $48.4M $0.16 -- --
06/30/2021 Q2 -- $48.8M $0.17 -- --
03/31/2021 Q1 -- $46.6M $0.16 -- --
12/31/2020 Q4 -- $43.9M $0.14 -- --
09/30/2020 Q3 -- $41.2M $0.16 -- --
06/30/2020 Q2 -- $39.6M $0.15 -- --
03/31/2020 Q1 -- $43M $0.11 -- --
12/31/2019 Q4 -- $47.5M $0.17 -- --
09/30/2019 Q3 -- $44.7M $0.14 -- --
06/30/2019 Q2 -- $40.1M $0.13 -- --
03/31/2019 Q1 -- $37.3M $0.11 -- --
12/31/2018 Q4 -- $36.8M $0.07 -- --
09/30/2018 Q3 -- $36.3M $0.08 -- --
06/30/2018 Q2 -- $36.7M $0.10 -- --
03/31/2018 Q1 $39.4M $36.6M $0.04 $0.13 -$0.09
12/31/2017 Q4 $38.3M $37M $0.09 $0.13 -$0.04
09/30/2017 Q3 -- $35.2M $0.09 -- --
06/30/2017 Q2 -- $32.7M $0.09 -- --
03/31/2017 Q1 -- $29.3M $0.07 -- --
12/31/2016 Q4 -- $29.1M $0.10 -- --
09/30/2016 Q3 -- $27.6M $0.03 -- --
06/30/2016 Q2 $26.2M $26.5M $0.03 $0.03 $0.00
03/31/2016 Q1 -- $24M $0.03 -- --
12/31/2015 Q4 -- $26.5M $0.10 -- --
09/30/2015 Q3 -- $27.2M $0.04 -- --
06/30/2015 Q2 -- $26.6M $0.03 -- --

Global Cord Blood Earnings Questions

  • How Much did Global Cord Blood Generate in Revenue Last Quarter?

    Global Cord Blood reported $46.8M worth of top line sales in its most recent quarter.

  • Did Global Cord Blood Beat Earnings Last Quarter?

    Global Cord Blood announced earnings per share of $0.14 which represents a beat of analyst forecast a -- per share.

  • Is Global Cord Blood Profitable?

    Global Cord Blood reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Global Cord Blood EPS Next Year?

    Global Cord Blood's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.

  • When is Global Cord Blood's Earnings Date?

    Global Cord Blood's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Should You Buy Alibaba Stock Despite the Risks?
Should You Buy Alibaba Stock Despite the Risks?

Markets rebounded slightly after U.S. President Donald Trump announced a…

Why Is Intel Struggling Against AMD?
Why Is Intel Struggling Against AMD?

Due to its disappointing reports, so-so management, and lack of…

Will PayPal Stock Recover or Keep Sliding?
Will PayPal Stock Recover or Keep Sliding?

Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
49
Is NVDA Stock a Buy?

Market Cap: $2.5T
P/E Ratio: 35x

Alerts

Buy
71
PEGA alert for Apr 24

Pegasystems [PEGA] is up 3.13% over the past day.

Buy
67
SMMT alert for Apr 24

Summit Therapeutics [SMMT] is up 10.38% over the past day.

Sell
36
ENPH alert for Apr 24

Enphase Energy [ENPH] is up 1.44% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock